Latest Publications
- Only a subset of Met-activated pathways are required to sustain oncogene addiction.
- Only a subset of Met-activated pathways are required to sustain oncogene addiction.
- Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition.
- A disintegrin and metalloproteinase-10 (ADAM-10) mediates DN30 antibody-induced shedding of the met surface receptor.
- Cell delivery of Met docking site peptides inhibit angiogenesis and vascular tumor growth.
- Genetic link between cancer and thrombosis.
- Molecular profiling of the "plexinome" in melanoma and pancreatic cancer.
- "Active" cancer immunotherapy by anti-Met antibody gene transfer.
- MicroRNAs impair MET-mediated invasive growth.
- Profiling YB-1 target genes uncovers a new mechanism for MET receptor regulation in normal and malignant human mammary cells.
- Prevention of hypoxia by myoglobin expression in human tumor cells promotes differentiation and inhibits metastasis.
- Inhibition of Src impairs the growth of met-addicted gastric tumors.
- Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice.
- Ron kinase transphosphorylation sustains MET oncogene addiction.
- MET signalling: principles and functions in development, organ regeneration and cancer.